Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what discussions he has had with the Chief Executive of NHS England on funding being made available in the next Comprehensive Spending Review to ensure the economic viability of independent pharmacies.
Answered by Jo Churchill
We are carefully considering the findings of the report on independent pharmacy in England and any implications for National Health Service arrangements under the Community Pharmacy Contractual Framework. As part of the 2020 Comprehensive Spending Review, funding for community pharmacy is being discussed, including with the Chief Executive Officer of the NHS in England.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, whether his Department through the Chief Executive of NHS England plans to provide (a) £300m required to cover the annual shortfall in costs undertaken by Pharmacy on behalf on the NHS and (b) indexation of future funding to support family pharmacies; and if he will make a statement.
Answered by Jo Churchill
We are carefully considering the findings of the report on independent pharmacy in England and any implications for National Health Service arrangements under the Community Pharmacy Contractual Framework. As part of the 2020 Comprehensive Spending Review, funding for community pharmacy is being discussed, including with the Chief Executive Officer of the NHS in England.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, with reference to the September 2020 report by EY on independent pharmacies, what assessment he has made of the implications for the primary care network of the rate of closure of independent community pharmacies staying at the rate indicated in that report over the next four years.
Answered by Jo Churchill
We are carefully considering the findings of the report on independent pharmacy in England and any implications for National Health Service arrangements under the Community Pharmacy Contractual Framework. As part of the 2020 Comprehensive Spending Review, funding for community pharmacy is being discussed, including with the Chief Executive Officer of the NHS in England.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, when his Department plans to update the House on its response to the Independent Medicines and Medical Devices Safety Review; what the Government's priorities are for women's health; and if he will make a statement.
Answered by Nadine Dorries
We do not consider it appropriate to commit to a specific timeframe for a response while these recommendations are being considered. While this report was published on 8 July, it took over two years to compile and we therefore consider it vitally important that it is given full consideration.
Supporting women’s health is critical for the health and care system. We know that there are significant differences and inequalities between different groups of women in terms of access to services, experience of services and health outcomes. We are reflecting on the detailed and thorough First Do No Harm Report published by Baroness Cumberlege and what this tells us about priorities for women’s health.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps he has taken to tackle the level of staff turnover in the GIDS Unit of the Tavistock and Portman NHS Foundation Trust since 2018.
Answered by Jo Churchill
Workforce issues are dealt with at local level by the management boards of individual trusts.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, what steps the NHS Gender Identity Development Service at the Tavistock Centre is taking to amend its services as a result of the updated guidance on the treatment of Gender Dysphoria published on 28 May 2020.
Answered by Jo Churchill
NHS England is currently undertaking a planned review of the Gender Identity Development Service for Children and Young People. The review will be informed by the outcome of work currently being led by the National Institute for Health and Care Excellence, which has been asked to establish the clinical and academic evidence that will inform a review of the use of hormone treatments.
The Gender Identity Development Service will continue to work to NHS England's current service specification and clinical commissioning policy during the period of review. Any proposals to amend the current service specification or clinical commissioning policy will be subject to public consultation in accordance with NHS England's established method and processes.
Asked by: Jackie Doyle-Price (Conservative - Thurrock)
Question to the Department of Health and Social Care:
To ask the Secretary of State for Health and Social Care, how many people the NHS Gender Identity Development Service at the Tavistock Centre referred to an endocrinologist in each of the last three years; and what the (a) age and (b) gender was of those those people .
Answered by Jo Churchill
This information is not available in the format requested.